Data-Driven Medicine Best Bet For Patient & Research Outcomes

Driving Medicine Forward When SOPHiA GENETICS, a healthcare technology company focused on data-driven medicine for life sciences research and listed among the 50 Smartest Companies by the MIT Technology Review, went public (Nasdaq: SOPH) on July 22nd of this year with a valuation at IPO of $1.1 billion, it was yet another indication of where deep …

Data-Driven Medicine Best Bet For Patient & Research Outcomes Read More »